Impact of Platelet Reactivity on Clinical Outcomes After Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Impact of Platelet Reactivity on Clinical Outcomes After Percutaneous Coronary Intervention

Published:2011-11 Issue:19 Volume:58 Page:1945-1954
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Brar Somjot S.,ten Berg Jurrien,Marcucci Rossella,Price Matthew J.,Valgimigli Marco,Kim Hyo-Soo,Patti Giuseppe,Breet Nicoline J.,DiSciascio Germano,Cuisset Thomas,Dangas George

Funder

Bristol-Myers Squibb

Sanofi-Aventis

Accumetrics

Iroko

Eli Lilly

Terumo

The Medicines Co.

Abbott

Eisai

AstraZeneca

Cordis

Medtronic

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;King;J Am Coll Cardiol,2008

2. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)

3. Bedside evaluation of thienopyridine antiplatelet therapy;Price;Circulation,2009

4. Clopidogrel non-responsiveness and risk of cardiovascular morbidity;Sofi;Thromb Haemost,2010

5. Rectangular confidence regions for the means of multivariate normal distributions;Sidak;J Am Stat Assoc,1967

Cited by 388 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients Following Acute Coronary Syndromes: From Lipid Lowering and Plaque Stabilization to Improved Outcomes;Journal of Clinical Medicine;2024-08-25

2. Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score;Heart and Vessels;2024-06-24

3. Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance;BMC Medical Genomics;2024-06-20

4. Clopidogrel resistance and its relevance: Current concepts;Journal of Family Medicine and Primary Care;2024-06

5. Platelet reactivity in patients with coronary artery disease undergoing dual antiplatelet therapy with aspirin and clopidogrel;Biomedical Research and Therapy;2024-05-31